Exhibit 99.1

Roadzen
Delivers First Positive Adjusted EBITDA Quarter in Company History on Record Revenue of $17.6 Million, Up 28.6% Year-Over-Year
Third
consecutive quarter of record revenue; ninth consecutive quarter of Adjusted EBITDA improvement; record first-half revenue up 37.6%;
a clear line of sight to a $100 million-plus annualized run rate; and an announced ~$10 million India subsidiary financing at an approximately
$300 million post-money valuation
Third
Consecutive Quarter of Record Revenue
Second
fiscal quarter revenue rose 28.6% year-over-year and 8.6% sequentially to a record $17.6 million, Roadzen’s third consecutive quarter
of record revenue, and first fiscal half revenue rose approximately 37.6% to a record $33.8 million from $24.5 million in the first half
of fiscal 2026.
First
Positive Adjusted EBITDA1 Quarter in Company History
Net
loss attributable to ordinary shareholders for the second quarter totaled $(4.1) million. Adjusted EBITDA¹ turned positive at $0.01
million in the second quarter of fiscal 2027 marking Roadzen’s ninth consecutive quarter of Adjusted EBITDA improvement.
India
Subsidiary Financing at a ~$300 Million Post-Money Valuation
Subsequent
to quarter-end, Roadzen announced an approximately $10 million (₹94 crore) equity financing for its India subsidiary, Roadzen AI
Limited, at an approximately $300 million post-money valuation. The financing is structured as straight common equity at the Indian subsidiary,
and proceeds will support growth and strengthen the balance sheet. The financing is expected to close in the coming weeks, subject to
customary closing conditions.
On
Track Toward a $100 Million-Plus Run Rate
Roadzen
exited the quarter at an annualized revenue run rate of approximately $70.3 million and continues to expect to exit fiscal 2027 at a
$100 million-plus annualized run rate, supported by contracted revenue ramping across the group and the pending acquisition of a European
MGA expected to add approximately $18–20 million of annual revenue.
Expanding
Operating Leverage as Revenue Growth Outpaces Expenses
Gross
profit grew 34.9% to $10.3 million, outpacing revenue growth, while gross margin expanded approximately 275 basis points to 58.5%. Operating
loss narrowed 24.0% to $2.5 million, with operating margin improving approximately 1,000 basis points to (14.4)%.
NEW
YORK, November 16, 2026 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a
global leader in AI at the convergence of insurance and mobility, today announced its financial results for the three and six months
ended September 30, 2026, the second quarter and first half of its fiscal year 2027.
¹
Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more
information, including a reconciliation to the nearest GAAP financial measure.
“This
is the quarter we have been building toward for two years. Roadzen generated positive Adjusted EBITDA for the first time in its history,
on record revenue of $17.6 million, our third record quarter in a row, after nine consecutive quarters of disciplined improvement,”
said Rohan Malhotra, Founder and CEO of Roadzen. “We got here while still growing first-half revenue by roughly 38%, which tells
us the operating model works at scale and that the revenue we add from here should carry more margin than the revenue that got us to
Adjusted EBITDA breakeven.”
Malhotra
continued, “We process more than three million claims a year, our driver-safety AI runs across billions of miles of real-world
driving, and our AI agents now do work inside inspection, claims and repair that used to take weeks, and that is the engine behind these
numbers. With the pending acquisition and the more than $30 million of revenue we announced in the first quarter ramping up, we have
line of sight to exiting fiscal 2027 at a $100 million-plus annualized run rate, and our job now is to expand from breakeven into sustained
profitability.”
“Turning
Adjusted EBITDA positive reflects the operating leverage we have built across the group, with revenue up 28.6% year-over-year while operating
expenses grew 19.1%,” stated Jean-Noël Gallardo, CFO of Roadzen. “Our priorities for the second half are clear: hold
Adjusted EBITDA positive, convert it into operating cash flow, and close the European acquisition.”
Second
Quarter and First Half Fiscal 2027 Financial Highlights
Revenue
and Key Performance Indicators:
| ● | Revenue
for the second quarter totaled a record $17.6 million, the Company’s third consecutive
quarter of record revenue, an increase of approximately $3.9 million, or 28.6%, over the
prior-year quarter, and 8.6% over the $16.2 million reported in the first quarter of fiscal
2027. |
| ● | Revenue
for the six months ended September 30, 2026 was a record $33.8 million, an increase of approximately
$9.3 million, or 37.6%, over the same period last year. |
| ● | Brokerage
revenue increased 43.4% to $8.4 million and IaaS revenue grew 17.4% to $9.2 million; brokerage
represented 47.8% of second-quarter revenue, with IaaS accounting for the remaining 52.2%.
First-half brokerage and IaaS revenue increased 35.9% to $15.7 million and 39.2% to $18.0
million, respectively. |
| ● | As
of September 30, 2026, Roadzen had 62 insurance customer agreements, 101 automotive customer
agreements and approximately 4,290 agent and fleet customer agreements, compared with 61
insurance, 96 automotive and approximately 4,240 agent and fleet customers as of June 30,
2026. |
| ● | Roadzen’s
brokerage business sold 187,454 policies during the second quarter, generating approximately
$23.8 million of Gross Written Premium (“GWP”), compared with 116,528 policies
and $12.4 million of GWP in the same quarter last year and 165,181 policies and $25.6 million
sequentially. First-half brokerage activity totaled 352,634 policies and approximately $49.4
million in GWP. |
| ● | In
the IaaS business, 1,816,011 claims, roadside assistance events and vehicle inspections were
conducted during the quarter, compared with 754,207 in the same quarter last year and 1,406,382
sequentially. |
| ● | Gross
margin for the quarter was 58.5%, compared with 55.7% in the same quarter last year. |
Operating
Expenses:
| ● | Cost
of Services increased 20.6% year-over-year to $7.3 million for the quarter and 35.2% to $14.2
million year to date, below revenue growth of 28.6% for the quarter and 37.6% year to date.
As a percentage of revenue, Cost of Services declined to 41.5% from 44.3% a year earlier. |
| ● | Operating
expenses excluding Cost of Services and Depreciation and Amortization increased 19.1% to
$12.2 million for the quarter. For the first half, comparable expenses increased 17.1% to
$22.2 million, significantly below revenue growth, demonstrating greater operating efficiency
as Roadzen scales. |
| ● | Second-quarter
operating loss narrowed 24.0% to $2.5 million from $3.3 million a year earlier, with operating
margin improving approximately 1,000 basis points to (14.4)% from (24.4)%. First-half operating
loss narrowed 30.4% to ($4.1) million from ($5.9) million, with operating margin improving
to (12.1)% from (23.9)%. |
Profitability
and Net Results:
| ● | Net
loss attributable to ordinary shareholders for the second quarter totaled $(4.1) million,
or $(0.05) per share, compared with $(2.1) million, or $(0.03) per share, in the same quarter
last year, and narrowed 58% sequentially from $(9.8) million. Results included approximately
$2.8 million in net interest expense, $0.4 million in fair-value gains and $0.6 million in
other income. |
| ● | Adjusted
EBITDA for the second quarter was $0.01 million, compared with a loss of $(1.1) million in
the prior-year quarter and $(0.37) million in the first quarter of fiscal 2027 — the
Company’s first quarter of positive Adjusted EBITDA and its ninth consecutive quarter
of Adjusted EBITDA improvement. First-half Adjusted EBITDA loss narrowed 85.4% to $(0.37)
million from $(2.5) million in the same period last year, an improvement of approximately
$2.1 million. |
Balance Sheet and Capital:
| ● | Total
assets were $49.7 million as of September 30, 2026, compared with $52.7 million at March
31, 2026. Cash and cash equivalents were $3.8 million, compared with $6.6 million at fiscal
year-end. Accounts receivable increased 41.4% to $10.6 million from $7.5 million at March
31, 2026. |
| ● | Total
liabilities were $83.2 million, compared with $79.2 million at fiscal year-end, while aggregate
borrowings increased approximately $0.3 million, or 1.0%, to $33.6 million. Higher current
maturities primarily reflect reclassification of existing obligations from long-term debt,
including the $11.5 million Mizuho senior secured facility. |
| ● | Net
cash used in operating activities declined 3.6% to $8.7 million for the six months ended
September 30, 2026, despite 37.6% revenue growth. Operating cash consumption improved to
25.7% of revenue from 36.7% a year earlier, an approximately 11-percentage-point improvement. |
Second
Quarter Fiscal 2027 Strategic and Operational Highlights
| ● | VehicleCare,
Roadzen’s AI-enabled claims-to-repair and embedded-insurance business, continued its
rapid scale-up and remains on course to grow revenue more than tenfold this fiscal year. |
| ● | drivebuddyAI,
the only driver-safety platform validated under both India’s AIS-184 standard and the
EU’s GSR 2144 regulation, continued to scale against safety mandates covering more
than one million new commercial vehicles in India annually, building on the $5.3 million
contract covering 3,600 electric buses and trucks announced earlier in fiscal 2027. |
| ● | Roadzen
is awaiting regulatory approvals for its acquisition of a leading European MGA specializing
in short-term car rental insurance, which is expected to add approximately $18–20 million
in annual revenue and $1.6–2.0 million in EBITDA. |
| ● | Roadzen’s
agentic AI platform continued to move work from people to agents across inspection, claims
and repair, cutting claims-to-repair cycle times from roughly six weeks to 48 hours for most
claims, drawing on more than three million claims processed annually and billions of miles
of real-world driving data. |
Subsequent
Financial Events
India
Subsidiary Financing:
| ● | On
November 16, 2026, Roadzen announced an approximately $10 million (₹94 crore) common-equity financing for its India subsidiary,
Roadzen AI Limited (formerly Roadzen Technologies Limited), at an approximately $300 million post-money valuation. Structured as straight
common equity, the financing carries no direct dilution at the Nasdaq-listed parent and is expected to close in approximately two weeks,
subject to customary closing conditions. Roadzen Inc., the Nasdaq-listed parent, will own approximately 89% of the Indian entity following
completion. Proceeds will support growth and strengthen the balance-sheet. |
For
more information about Roadzen Inc., please visit https://www.roadzen.ai.
About
Roadzen Inc.
Roadzen
Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers,
automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences.
Thousands
of clients — from the world’s leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen’s
technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics,
generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world’s top
AI innovators.
Headquartered
in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India and China. Learn more at https://roadzen.ai.
Cautionary
Statement Regarding Forward Looking Statements
This
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and
projections about future events, including statements regarding our expected revenue run rate and path to profitability, our ability
to sustain positive Adjusted EBITDA and generate operating cash flow, the closing, timing, size and use of proceeds of the India subsidiary
financing, the completion and expected contribution of the pending European MGA acquisition, the ramp of contracted revenue, expected
growth at VehicleCare and drivebuddyAI, expansion of U.S. commercial sales, our corporate structure, our anticipated strategy, and future
operating results. These statements are subject to known and unknown risks, uncertainties, and assumptions that may cause actual results
to differ materially from those expressed or implied. In some cases you can identify forward-looking statements by terms such as “may,”
“should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,”
“estimate,” and “continue,” or the negative of such terms. Factors that might cause a discrepancy include our
inability to obtain consent of our senior lender to complete the India financing described in this release, as well as those described
under “Risk Factors” in our SEC filings, including the annual report on Form 10-K filed on June 29, 2026, and our subsequent
quarterly reports on Form 10-Q. All subsequent written or oral forward-looking statements attributable to the Company or persons acting
on its behalf are expressly qualified by these cautionary statements. The forward-looking statements in this release are made only as
of the date hereof, and except as required by applicable securities law, we disclaim any obligation to update or revise them.
For
more information, please contact:
Investor
Contacts: IR@roadzen.ai
Media
Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai
Roadzen
Inc.
Unaudited
Condensed Consolidated Balance Sheets
(in
US $, except share count)
| Particulars | |
As of September 30, 2026 | | |
As of March 31, 2026 | |
| Assets | |
| | | |
| | |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
| 3,798,064 | | |
| 6,578,594 | |
| Accounts receivable, net | |
| 10,605,587 | | |
| 7,500,439 | |
| Inventories | |
| 387,009 | | |
| 116,555 | |
| Prepayments and other current assets | |
| 12,285,669 | | |
| 17,833,119 | |
| Investments | |
| 288,875 | | |
| 229,994 | |
| Total current assets | |
| 27,365,204 | | |
| 32,258,701 | |
| Non current assets | |
| | | |
| | |
| Restricted cash | |
| 218,470 | | |
| 222,026 | |
| Property and equipment, net | |
| 720,950 | | |
| 536,997 | |
| Goodwill | |
| 7,563,954 | | |
| 7,616,973 | |
| Operating lease right-of-use assets | |
| 1,959,567 | | |
| 1,374,147 | |
| Intangible assets, net | |
| 10,868,244 | | |
| 9,651,915 | |
| Other long-term assets | |
| 1,047,619 | | |
| 997,802 | |
| Total Non current assets | |
| 22,378,804 | | |
| 20,399,860 | |
| Total assets | |
| 49,744,008 | | |
| 52,658,561 | |
| | |
| | | |
| | |
| Liabilities and shareholders’ Equity/(Deficit) | |
| | | |
| | |
| Current liabilities | |
| | | |
| | |
| Current portion of long-term borrowings | |
| 25,772,912 | | |
| 9,829,713 | |
| Short-term borrowings | |
| 7,558,500 | | |
| 7,843,267 | |
| Accounts payable and accrued expenses | |
| 34,396,718 | | |
| 30,245,947 | |
| Derivative warrant liabilities | |
| 2,175,953 | | |
| 1,987,003 | |
| Short-term operating lease liabilities | |
| 620,938 | | |
| 325,255 | |
| Other current liabilities | |
| 9,655,576 | | |
| 8,072,789 | |
| Total current liabilities | |
| 80,180,597 | | |
| 58,303,974 | |
| Non current liabilities | |
| | | |
| | |
| Long-term borrowings | |
| 294,874 | | |
| 15,612,108 | |
| Long-term operating lease liabilities | |
| 1,072,470 | | |
| 699,817 | |
| Other long-term liabilities | |
| 1,615,940 | | |
| 4,561,246 | |
| Total Non current liabilities | |
| 2,983,284 | | |
| 20,873,171 | |
| Total liabilities | |
| 83,163,881 | | |
| 79,177,145 | |
| | |
| | | |
| | |
| Commitments and contingencies (refer note 20) | |
| | | |
| | |
| | |
| | | |
| | |
| Shareholders’ Equity/(Deficit) | |
| | | |
| | |
| Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of September 30, 2026 and March 31, 2026; 85,295,834 and 79,695,672 shares outstanding as of September 30, 2026 and March 31, 2026 respectively | |
| 119,271,010 | | |
| 112,128,293 | |
| Accumulated deficit | |
| (260,058,012 | ) | |
| (246,224,660 | ) |
| Accumulated other comprehensive income/(loss) | |
| (1,377,007 | ) | |
| (1,299,868 | ) |
| Other components of equity | |
| 105,657,703 | | |
| 105,747,998 | |
| Total shareholders’ deficit | |
| (36,506,306 | ) | |
| (29,648,237 | ) |
| Non-controlling interest | |
| 3,086,433 | | |
| 3,129,653 | |
| Total deficit | |
| (33,419,873 | ) | |
| (26,518,584 | ) |
| Total liabilities and Total Deficit | |
| 49,744,008 | | |
| 52,658,561 | |
The
accompanying notes are an integral part of these consolidated financial statements.
Roadzen
Inc.
Unaudited
Condensed Consolidated Statements of Operations
(in
US $, except share count)
| |
For the three months ended
September 30, | | |
For the six months ended
September 30, | |
| Particulars | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Revenue | |
| 17,585,523 | | |
| 13,679,267 | | |
| 33,779,847 | | |
| 24,544,813 | |
| Costs and expenses: | |
| | | |
| | | |
| - | | |
| | |
| Cost of services | |
| 7,304,373 | | |
| 6,057,579 | | |
| 14,228,162 | | |
| 10,527,032 | |
| Research and development | |
| 394,630 | | |
| 148,529 | | |
| 813,745 | | |
| 230,063 | |
| Sales and marketing | |
| 7,737,345 | | |
| 6,252,328 | | |
| 14,943,472 | | |
| 12,384,339 | |
| General and administrative | |
| 4,026,440 | | |
| 3,806,800 | | |
| 6,485,164 | | |
| 6,384,698 | |
| Depreciation and amortization | |
| 657,545 | | |
| 750,207 | | |
| 1,387,061 | | |
| 875,206 | |
| Total costs and expenses | |
| 20,120,333 | | |
| 17,015,443 | | |
| 37,857,604 | | |
| 30,401,338 | |
| Loss from operations | |
| (2,534,810 | ) | |
| (3,336,176 | ) | |
| (4,077,757 | ) | |
| (5,856,525 | ) |
| Interest expense (net) | |
| (2,761,762 | ) | |
| (1,249,540 | ) | |
| (5,616,461 | ) | |
| (2,190,859 | ) |
| Fair value gains/(losses) in financial instruments carried at fair value | |
| 395,161 | | |
| 1,067,732 | | |
| (6,815,704 | ) | |
| 556,194 | |
| Other income (net) | |
| 626,614 | | |
| 1,353,929 | | |
| 2,464,371 | | |
| 1,306,007 | |
| Total other income/(expense) | |
| (1,739,987 | ) | |
| 1,172,121 | | |
| (9,967,794 | ) | |
| (328,658 | ) |
| (Loss)/Income before income tax expense | |
| (4,274,797 | ) | |
| (2,164,055 | ) | |
| (14,045,551 | ) | |
| (6,185,183 | ) |
| Less: income tax (benefit)/expense | |
| (104,717 | ) | |
| 10,826 | | |
| (111,337 | ) | |
| 90,805 | |
| Net (loss)/income before non-controlling interest | |
| (4,170,080 | ) | |
| (2,174,881 | ) | |
| (13,934,214 | ) | |
| (6,275,988 | ) |
| Net loss attributable to non-controlling interest, net of tax | |
| (86,601 | ) | |
| (66,777 | ) | |
| (56,361 | ) | |
| (162,114 | ) |
| Net Loss attributable to Ordinary shareholders | |
| (4,083,479 | ) | |
| (2,108,104 | ) | |
| (13,877,853 | ) | |
| (6,113,874 | ) |
| Net loss per share attributable to Ordinary shareholders | |
| | | |
| | | |
| | | |
| | |
| Basic and diluted | |
| (0.05 | ) | |
| (0.03 | ) | |
| (0.17 | ) | |
| (0.08 | ) |
| Weighted-average number of shares used in computing net loss per share | |
| 84,911,075 | | |
| 75,671,838 | | |
| 83,818,148 | | |
| 75,671,838 | |
The
accompanying notes are an integral part of these consolidated financial statements.
Roadzen
Inc.
Unaudited
Condensed Consolidated Statements of Cash Flow
(in
US $, except share count)
| |
For the Period ended
September 30, | |
| Particulars | |
2026 | | |
2025 | |
| Cash flows from operating activities | |
| | | |
| | |
| Net Loss attributable to Ordinary shareholders | |
| (13,877,853 | ) | |
| (6,113,874 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
| Depreciation and amortization | |
| 1,387,061 | | |
| 875,206 | |
| Stock based compensation | |
| 247,958 | | |
| 133,734 | |
| Deferred income taxes | |
| (130,320 | ) | |
| (1,263 | ) |
| Unrealized foreign exchange loss/(profit) | |
| (65,305 | ) | |
| (62,074 | ) |
| Expenses settled through issuance of Ordinary Shares | |
| 866,786 | | |
| - | |
| Fair value losses/(profits) in financial instruments carried at fair value | |
| 6,815,704 | | |
| (556,194 | ) |
| Expected credit loss (net of reversal) | |
| 172,724 | | |
| 25,572 | |
| Balances written off/(back) | |
| (1,793,721 | ) | |
| (1,331,258 | ) |
| Net total loss attributable to non-controlling interest, net of tax | |
| (56,361 | ) | |
| (162,114 | ) |
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | |
| | | |
| | |
| Inventories | |
| (270,454 | ) | |
| (11,340 | ) |
| Accounts receivables, net | |
| (4,381,760 | ) | |
| 417,176 | |
| Prepayments and other assets | |
| (2,082,444 | ) | |
| (6,073,975 | ) |
| Accounts payable and accrued expenses | |
| 1,784,029 | | |
| 3,107,115 | |
| Other liabilities | |
| 2,707,332 | | |
| 754,275 | |
| Net cash used in operating activities | |
| (8,676,624 | ) | |
| (8,999,014 | ) |
| Cash flows from investing activities | |
| | | |
| | |
| Purchase of property and equipment & intangible assets | |
| (1,333,299 | ) | |
| (355,635 | ) |
| Consideration paid for business acquired in prior year | |
| (925,000 | ) | |
| - | |
| Investment in mutual funds and bonds | |
| (58,881 | ) | |
| (28,213 | ) |
| Net cash used in investing activities | |
| (2,317,180 | ) | |
| (383,848 | ) |
| Cash flows from financing activities | |
| | | |
| | |
| Proceeds from issue of ordinary shares | |
| 7,460,000 | | |
| 3,694,459 | |
| Proceeds from issue of equity shares of subsidiary | |
| - | | |
| 5,778,944 | |
| Net proceeds/(payments) from borrowings | |
| 749,718 | | |
| (941,862 | ) |
| Net cash generated from financing activities | |
| 8,209,718 | | |
| 8,531,541 | |
| Effect of exchange rate changes on cash and cash equivalents | |
| - | | |
| 62,972 | |
| Net (decrease)/increase in cash and cash equivalents (including restricted cash) | |
| (2,784,086 | ) | |
| (788,349 | ) |
| Cash acquired in business combination | |
| - | | |
| 928,074 | |
| Cash and cash equivalents at the beginning of the period (including restricted cash) | |
| 6,800,620 | | |
| 5,053,654 | |
| Cash and cash equivalents at the end of the period (including restricted cash) | |
| 4,016,534 | | |
| 5,193,379 | |
| | |
| | | |
| | |
| Reconciliation of cash and cash equivalents | |
| | | |
| | |
| Cash and cash equivalents | |
| 3,798,064 | | |
| 4,973,633 | |
| Restricted cash | |
| 218,470 | | |
| 219,746 | |
| Total cash and cash equivalents | |
| 4,016,534 | | |
| 5,193,379 | |
| | |
| | | |
| | |
| Supplemental disclosure of cash flow information | |
| | | |
| | |
| Cash paid for interest, net of amounts capitalized | |
| 2,999,719 | | |
| 1,707,711 | |
| Non-cash investing and financing activities | |
| | | |
| | |
| Consideration payable in connection with acquisitions | |
| 1,024,926 | | |
| 488,000 | |
| Interest accrued on borrowings | |
| 4,746,930 | | |
| 2,652,119 | |
The
accompanying notes are an integral part of these consolidated financial statements.
Non-GAAP
Financial Measures
This
press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”), a non-GAAP
financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported
net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash
depreciation and amortization and certain non-recurring and other items to help clarify sustainability and trends affecting the business.
For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating
business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance
prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flows provided by, or used for,
operating activities in accordance with GAAP and should not be used as a measure of liquidity.
Non-GAAP
financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information
presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial
measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently
or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures
as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP
financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate
our business.
The
following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
| | |
For the three months ended
September 30, | |
| Particulars | |
2026 | | |
2025 | |
| Net loss | |
| (4,083,479 | ) | |
| (2,108,104 | ) |
| Adjusted for: | |
| | | |
| | |
| Other (income)/expense net | |
| (626,614 | ) | |
| (1,353,929 | ) |
| Interest (income)/expense | |
| 2,761,762 | | |
| 1,249,540 | |
| Fair value changes in financial instruments carried at fair value | |
| (395,161 | ) | |
| (1,067,732 | ) |
| Tax (benefit)/expense | |
| (104,717 | ) | |
| 10,826 | |
| Depreciation and amortization | |
| 657,545 | | |
| 750,207 | |
| Stock based compensation expense | |
| 88,831 | | |
| 62,381 | |
| Non-cash expenses | |
| 1,287,474 | | |
| 132,841 | |
| Non-recurring expenses | |
| 422,560 | | |
| 1,231,747 | |
| Adjusted EBITDA | |
| 8,201 | | |
| (1,092,224 | ) |
| | |
For the Six months ended
September 30, | |
| Particulars | |
2026 | | |
2025 | |
| Net loss | |
| (13,877,853 | ) | |
| (6,113,874 | ) |
| Adjusted for: | |
| | | |
| | |
| Other (income)/expense net | |
| (2,464,371 | ) | |
| (1,306,007 | ) |
| Interest (income)/expense | |
| 5,616,461 | | |
| 2,190,859 | |
| Fair value changes in financial instruments carried at fair value | |
| 6,815,704 | | |
| (556,194 | ) |
| Tax (benefit)/expense | |
| (111,337 | ) | |
| 90,805 | |
| Depreciation and amortization | |
| 1,387,061 | | |
| 875,206 | |
| Stock based compensation expense | |
| 247,958 | | |
| 133,739 | |
| Non-cash expenses | |
| 530,106 | | |
| 439,555 | |
| Non-recurring expenses | |
| 1,490,462 | | |
| 1,747,849 | |
| Adjusted EBITDA | |
| (365,809 | ) | |
| (2,498,062 | ) |